Influence of impaired glucose tolerance alone and combined with metabolic syndrome on long-term risk of cardiovascular events and mortality

被引:2
作者
Chen, Fei [1 ]
He, Yifan [1 ]
Wang, Jinping [2 ]
Yu, Liping [1 ]
Gong, Qiuhong [3 ]
Chen, Yanyan [3 ]
An, Yali [3 ]
He, Siyao [3 ]
Li, Guangwei [1 ,3 ]
Zhang, Bo [1 ]
机构
[1] China Japan Friendship Hosp, Dept Endocrinol, 2 Yinghuayuan East St, Beijing 100029, Peoples R China
[2] Da Qing First Hosp, Dept Cardiol, Da Qing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Endocrinol Ctr, Beijing, Peoples R China
关键词
cardiovascular events; impaired glucose tolerance; metabolic syndrome; mortality; LIFE-STYLE INTERVENTION; QING DIABETES PREVENTION; ALL-CAUSE MORTALITY; FOLLOW-UP; REDUCTION; PEOPLE;
D O I
10.1111/1753-0407.13598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThis study aimed to investigate the potential differences in the influence of impaired glucose tolerance (IGT) with and without metabolic syndrome (MetS) on cardiovascular (CV) events and mortality.MethodsParticipants having IGT with MetS (IGT_MetS), those having IGT without MetS (IGT_non_MetS), and those having normal glucose tolerance (NGT) without MetS (NGT_non_MetS) (N = 246, N = 294, and N = 471, respectively) were included in this study. Cox proportional hazards regression was used to examine the relationship among these three groups and CV events and mortality.ResultsOver the 30-year follow-up period, 57 (12.1%) participants having NGT_non_MetS, 55 (18.71%) with IGT_non_MetS, and 74 (30.08%) with IGT_MetS experienced CV mortality. After adjusting for risk factors, the hazard ratios for CV mortality were 2 (95% confidence interval [CI], 1.38-2.91) for the IGT_non_MetS group and 2.96 (95% CI, 2.09-4.19) for the IGT_MetS group, compared with the NGT_non_MetS group. Similar patterns were observed for CV events, with hazard ratios of 1.49 (95% CI, 1.19-1.88) for the IGT_non_MetS group and 1.97 (95% CI, 1.58-2.47) for the IGT_MetS group. Sensitivity analysis revealed that the hazard ratios of the IGT_non_MetS and IGT_MetS groups indicated a higher risk of all-cause mortality, myocardial infarction events or myocardial infarction mortality, and stroke events or stroke mortality compared with that of the NGT_non_MetS group.ConclusionIGT_non_MetS increased the risk of CV mortality and events. Furthermore, when it occurred in conjunction with MetS, it further increased the risk of CV mortality and events. This suggested that active intervention is required. imageConclusionIGT_non_MetS increased the risk of CV mortality and events. Furthermore, when it occurred in conjunction with MetS, it further increased the risk of CV mortality and events. This suggested that active intervention is required. image HighlightsThe IGT_non_MetS or IGT_MetS increased the risk of CV mortality and events. We found that the IGT_non_MetS and IGT_MetS groups had higher risk of all-cause mortality, MI events or MI mortality, and stroke events or stroke mortality compared with the NGT_non_MetS group. Tailoring interventions according to whether IGT was accompanied by MetS can potentially maximize cost-effectiveness, especially within the constraints of limited medical resources. image
引用
收藏
页数:10
相关论文
共 28 条
[1]   Cardiovascular and All-Cause Mortality Over a 23-Year Period Among Chinese With Newly Diagnosed Diabetes in the Da Qing IGT and Diabetes Study [J].
An, Yali ;
Zhang, Ping ;
Wang, Jinping ;
Gong, Qiuhong ;
Gregg, Edward W. ;
Yang, Wenying ;
Li, Hui ;
Zhang, Bo ;
Shuai, Ying ;
Chen, Yanyan ;
Engelgau, Michael M. ;
Cheng, Yiling ;
Hu, Yinghua ;
Bennett, Peter H. ;
Li, Guangwei .
DIABETES CARE, 2015, 38 (07) :1365-1371
[2]  
Cai XY, 2020, BMJ-BRIT MED J, V370, DOI [10.1136/bmi.m2297, 10.1136/bmj.m2297]
[3]   Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study [J].
Chen, Yanyan ;
Zhang, Ping ;
Wang, Jinping ;
Gong, Qiuhong ;
An, Yali ;
Qian, Xin ;
Zhang, Bo ;
Li, Hui ;
Gregg, Edward W. ;
Bennett, Peter H. ;
Li, Guangwei .
DIABETOLOGIA, 2021, 64 (06) :1279-1287
[4]   The Metabolic Syndrome [J].
Cornier, Marc-Andre ;
Dabelea, Dana ;
Hernandez, Teri L. ;
Lindstrom, Rachel C. ;
Steig, Amy J. ;
Stob, Nicole R. ;
Van Pelt, Rachael E. ;
Wang, Hong ;
Eckel, Robert H. .
ENDOCRINE REVIEWS, 2008, 29 (07) :777-822
[5]   Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017 [J].
Einarson, Thomas R. ;
Acs, Annabel ;
Ludwig, Craig ;
Panton, Ulrik H. .
CARDIOVASCULAR DIABETOLOGY, 2018, 17
[6]  
Einhorn Daniel, 2003, Endocr Pract, V9, P237
[7]  
ElSayed NA, 2023, DIABETES CARE, V46, pS5, DOI [10.2337/dc23-Srev, 10.2337/dc23-SREV]
[8]   Metabolic syndrome and risk of incident cardiovascular events and death - A systematic review and meta-analysis of longitudinal studies [J].
Gami, Apoor S. ;
Witt, Brandi J. ;
Howard, Daniel E. ;
Erwin, Patricia J. ;
Gami, Lisa A. ;
Somers, Virend K. ;
Montori, Victor M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (04) :403-414
[9]   Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study [J].
Gong, Qiuhong ;
Zhang, Ping ;
Wang, Jinping ;
Ma, Jixiang ;
An, Yali ;
Chen, Yanyan ;
Zhang, Bo ;
Feng, Xinxing ;
Li, Hui ;
Chen, Xiaoping ;
Cheng, Yiling J. ;
Gregg, Edward W. ;
Hu, Yinghua ;
Bennett, Peter H. ;
Li, Guangwei .
LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (06) :452-461
[10]   Pre-Diabetes, Metabolic Syndrome, and Cardiovascular Risk [J].
Grundy, Scott M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (07) :635-643